Sign in

CIK 0001818794

  • Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364883909
Phone
+1 781-786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 4 Open-market sale Chief Operating Officer sold 9,939 shares at $7.40 ($73,549)
  2. 4 Open-market sale See Remarks sold 1,290 shares at $9.41 ($12,139)
  3. 4 Open-market sale Chief Business Officer sold 1,261 shares at $9.41 ($11,866)
  4. 4 Open-market sale Chief Operating Officer sold 2,672 shares at $9.41 ($25,144)
  5. 4 Open-market sale See Remarks sold 12,032 shares at $9.41 ($113,221)
  6. 4 Open-market sale Chief Scientific Officer sold 1,436 shares at $9.41 ($13,513)
  7. 4 Open-market sale Chief Medical Officer sold 1,707 shares at $10.41 ($17,770)
  8. 4 Open-market sale See Remarks sold 1,397 shares at $10.41 ($14,543)
  9. 4 Planned sale Chief Business Officer sold 1,266 shares at $10.41 ($13,179)
  10. 4 Open-market sale Chief Operating Officer sold 1,635 shares at $10.41 ($17,020)
  11. 4 Open-market sale See Remarks sold 7,672 shares at $10.41 ($79,866)
  12. 4 Open-market sale Chief Scientific Officer sold 1,484 shares at $10.41 ($15,448)
  13. 4 Open-market sale See Remarks sold 51,390 shares at an average $12.71 ($653,178)
  14. 4 Planned sale See Remarks sold 2,259 shares at an average $12.68 ($28,649)
  15. 4 Open-market sale Chief Operating Officer sold 1,625 shares at $12.43 ($20,199)
  16. 4 Open-market sale Chief Medical Officer sold 1,698 shares at $12.43 ($21,106)
  17. 4 Open-market sale Chief Scientific Officer sold 1,475 shares at $12.43 ($18,334)
  18. 4 Open-market sale See Remarks sold 325,330 shares at an average $12.90 ($4,195,797)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 19 · 365 filings